3Cardiac pathology of extracardiac origin (Ⅱ). The cardiac repercus-sion of amyloidosis and hemochromatosis [J]. Rev Esp Cardiol, 1997, 50 ( 11 ) : 790 - 801.
4Dubrey SW, Cha K, Anderson J, et al. The clinical features of im- munoglobulin light-chain (AL) amyloidosis with heart involvement [J]. QJM, 1998,91(2): 141.
5Chamarthi B, Dubrey SW, Cha K, et al. Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis [J]. Am J Cardiol, 1997, 80:1242 - 1245.
7A1 Suwaidi ], Velianou JL, Gertz MA, et al. Systemic amyloidosis pres- enting with angina pectoris[J]. Ann Intern Med, 1999, 131:838.
8Dubrey SW, Bilazarian S, LaValley Met al. Signal-averaged elec- trocardiography in patients with AL (primary) amyloidosis [ J ]. Am Heart J, 1997, 134:994 - 1001.
9Perugini E, Rapezzi C, Piva T, et al. Non-invasive evaluation of tbe myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance[ J]. Heart, 2006, 92:343 - 349.
10Kwong RY, Falk RH. Cardiovascular magnetic resonance in cardiac amyloidosis[ J]. Circulation, 2005, 111 : 122.
